Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Lewy Body Dementia Market Report 2025

Lewy Body Dementia Global Market Report 2025 - By Diagnosis (Clinical Diagnosis, Biomarker-Based Diagnosis), By Medication (Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications), By End-User (Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Lewy Body Dementia Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Lewy Body Dementia Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Lewy Body Dementia Market

Lewy body dementia (LBD) is a neurodegenerative condition caused by abnormal protein deposits in the brain, impacting cognition, movement, and behavior. This results in a gradual decline in both mental and physical abilities, with symptoms including memory loss, hallucinations, tremors, and motor difficulties. Effective management is essential to address the cognitive and physical challenges associated with the disorder.

The main diagnosis types of lewy body dementia are Clinical Diagnosis and biomarker-based diagnosis. Clinical diagnosis involves identifying diseases like Lewy body dementia based on medical history, symptoms, and physical exams, aiding early recognition and treatment. It is treated with various medications, such as cholinesterase inhibitors, antipsychotics, antidepressants, and others, and used by various end-users, including hospitals, specialty clinics, long-term care facilities, and others.

How Is The Lewy Body Dementia Market Segmented?

The lewy body dementia market covered in this report is segmented –

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers

Lewy Body Dementia Market Size and growth rate 2025 to 2029: Graph

What Is The Lewy Body Dementia Market Size 2025 And Growth Rate?

The lewy body dementia market size has grown strongly in recent years. It will grow from $1.12 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population growth, increasing awareness of neurodegenerative diseases, rise in healthcare expenditures, improved diagnostic criteria, and regulatory approvals for dementia drugs.

What Is The Lewy Body Dementia Market Growth Forecast?

The lewy body dementia market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing prevalence of dementia, growing investment in research and development, rising demand for early diagnosis, expanding telemedicine adoption, and focus on personalized medicine. Major trends in the forecast period include development of targeted therapies, expansion of clinical trials, advances in diagnostic techniques, technological advancements, and emphasis on novel therapeutics.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Lewy Body Dementia Market: Rising Prevalence Of Brain-Related Disorders Driving The Market Growth

The rise in the prevalence of brain-related disorders is expected to propel the growth of the lewy body dementia market going forward. Brain-related disorders refer to a range of conditions affecting the brain’s structure and function, leading to cognitive decline, memory loss, and behavioral changes. The prevalence of brain-related disorders is increasing due to factors such as aging, genetic predisposition, and environmental influences. The increasing prevalence of brain-related disorders boosts the demand for better treatments and early detection for lewy body dementia, which in turn drives research, funding, and innovation, leading to faster advancements in diagnosis and therapy for LBD. For instance, in October 2023, according to the World Federation of Neurology, the UK-based association of national neurological societies, more than 40% of the global population is affected by neurological conditions, with this burden expected to almost double by 2050. Therefore, the rise in the prevalence of brain-related disorders will drive the growth of the lewy body dementia market.

Who Are The Major Players In The Global Lewy Body Dementia Market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

What Are The Key Trends Of The Global Lewy Body Dementia Market: Research Investments Driving Advancements In Lewy Body Dementia Treatment

Major companies operating in the lewy body dementia market are focusing on research investment to develop more effective neurodegenerative treatments. Research investment involves dedicating financial resources, time, and effort to scientific and technological studies aimed at uncovering new insights, developing innovative solutions, or enhancing current practices. It supports the exploration of diseases and the creation of new medications, all with the ultimate goal of improving patient outcomes. For instance, in March 2023, the National Institute on Aging, a US-based government agency, awarded $21 million to support drug development research for Lewy Body Dementia (LBD). Researchers at the University of Miami Miller School of Medicine are initiating a Phase 2b study of neflamapimod following encouraging early results.

What Are Latest Mergers And Acquisitions In The Lewy Body Dementia Market: CND Life Sciences Partnered With Beth Israel Deaconess Medical Center To Enhance Diagnostic Accuracy For Neurodegenerative Disorders

In March 2023, CND Life Sciences, a US-based developer of highly accurate skin-based tests to help clinicians diagnose dementia with Lewy bodies, partnered with Beth Israel Deaconess Medical Center (BIDMC) to enhance its skin-based diagnostic tool for neurodegenerative diseases. This partnership aims to leverage advanced technology to improve the detection of misfolded alpha-synuclein proteins and explore additional protein markers associated with other neurodegenerative disorders, ultimately facilitating more accurate diagnoses and better patient outcomes as new therapies emerge. Beth Israel Deaconess Medical Center (BIDMC) is a US-based company specializing in diagnosing and treating conditions such as Lewy body disease.

What Is The Regional Outlook For The Global Lewy Body Dementia Market?

North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lewy body dementia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lewy Body Dementia  Market?

The lewy body dementia market consists of revenues earned by entities by providing services such as cognitive and motor function therapies, pharmaceutical treatments, and physical therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lewy body dementia market also includes sales of sleep aids, mood stabilizers, and anxiolytics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lewy Body Dementia  Industry?

The lewy body dementia market research report is one of a series of new reports from The Business Research Company that provides lewy body dementia market statistics, including the lewy body dementia industry global market size, regional shares, competitors with the lewy body dementia market share, detailed lewy body dementia market segments, market trends, and opportunities, and any further data you may need to thrive in the lewy body dementia industry. This lewy body dementia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Lewy Body Dementia Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $1.21 billion
Revenue Forecast In 2034 $1.60 billion
Growth Rate CAGR of 7.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The lewy body dementia market covered in this report is segmented –
1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications
3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Lewy Body Dementia Market Characteristics

    3. Lewy Body Dementia Market Trends And Strategies

    4. Lewy Body Dementia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Lewy Body Dementia Growth Analysis And Strategic Analysis Framework

    5.1. Global Lewy Body Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Lewy Body Dementia Market Growth Rate Analysis

    5.4. Global Lewy Body Dementia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Lewy Body Dementia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Lewy Body Dementia Total Addressable Market (TAM)

    6. Lewy Body Dementia Market Segmentation

    6.1. Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Clinical Diagnosis

    Biomarker-Based Diagnosis

    6.2. Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cholinesterase Inhibitors

    Antipsychotics

    Antidepressants

    Other Medications

    6.3. Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Specialty Clinics

    Long-Term Care Facilities

    Other End-Users

    6.4. Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Neuropsychological Testing

    Neurological Examination

    Medical History Review

    Cognitive Function Assessment

    6.5. Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cerebrospinal Fluid (CSF) Biomarkers

    Imaging Biomarkers (PET, MRI)

    Genetic Biomarkers

    Blood-Based Biomarkers

    7. Lewy Body Dementia Market Regional And Country Analysis

    7.1. Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Lewy Body Dementia Market

    8.1. Asia-Pacific Lewy Body Dementia Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Lewy Body Dementia Market

    9.1. China Lewy Body Dementia Market Overview

    9.2. China Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Lewy Body Dementia Market

    10.1. India Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Lewy Body Dementia Market

    11.1. Japan Lewy Body Dementia Market Overview

    11.2. Japan Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Lewy Body Dementia Market

    12.1. Australia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Lewy Body Dementia Market

    13.1. Indonesia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Lewy Body Dementia Market

    14.1. South Korea Lewy Body Dementia Market Overview

    14.2. South Korea Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Lewy Body Dementia Market

    15.1. Western Europe Lewy Body Dementia Market Overview

    15.2. Western Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Lewy Body Dementia Market

    16.1. UK Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Lewy Body Dementia Market

    17.1. Germany Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Lewy Body Dementia Market

    18.1. France Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Lewy Body Dementia Market

    19.1. Italy Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Lewy Body Dementia Market

    20.1. Spain Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Lewy Body Dementia Market

    21.1. Eastern Europe Lewy Body Dementia Market Overview

    21.2. Eastern Europe Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Lewy Body Dementia Market

    22.1. Russia Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Lewy Body Dementia Market

    23.1. North America Lewy Body Dementia Market Overview

    23.2. North America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Lewy Body Dementia Market

    24.1. USA Lewy Body Dementia Market Overview

    24.2. USA Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Lewy Body Dementia Market

    25.1. Canada Lewy Body Dementia Market Overview

    25.2. Canada Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Lewy Body Dementia Market

    26.1. South America Lewy Body Dementia Market Overview

    26.2. South America Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Lewy Body Dementia Market

    27.1. Brazil Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Lewy Body Dementia Market

    28.1. Middle East Lewy Body Dementia Market Overview

    28.2. Middle East Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Lewy Body Dementia Market

    29.1. Africa Lewy Body Dementia Market Overview

    29.2. Africa Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Lewy Body Dementia Market Competitive Landscape And Company Profiles

    30.1. Lewy Body Dementia Market Competitive Landscape

    30.2. Lewy Body Dementia Market Company Profiles

    30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Georgetown University Medical Center Overview, Products and Services, Strategy and Financial Analysis

    31. Lewy Body Dementia Market Other Major And Innovative Companies

    31.1. Alzheimer's Society

    31.2. BioArctic AB

    31.3. Annovis Bio Inc.

    31.4. Sun Pharma Advanced Research Company Limited

    31.5. Voyager Therapeutics Inc.

    31.6. Cognition Therapeutics

    31.7. Athira Pharma

    31.8. Allergan plc

    31.9. Inhibikase Therapeutics

    31.10. CuraSen Therapeutics Inc.

    31.11. CervoMed Inc.

    31.12. AC Immune SA

    31.13. ProMIS Neurosciences Inc.

    31.14. Aptinyx Inc.

    31.15. EIP Pharma Inc.

    32. Global Lewy Body Dementia Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Lewy Body Dementia Market

    34. Recent Developments In The Lewy Body Dementia Market

    35. Lewy Body Dementia Market High Potential Countries, Segments and Strategies

    35.1 Lewy Body Dementia Market In 2029 - Countries Offering Most New Opportunities

    35.2 Lewy Body Dementia Market In 2029 - Segments Offering Most New Opportunities

    35.3 Lewy Body Dementia Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Eli Lilly and Company Financial Performance
  • Table 77: Mayo Foundation for Medical Education and Research Financial Performance
  • Table 78: Eisai Co. Ltd. Financial Performance
  • Table 79: Sumitomo Dainippon Pharma Co. Ltd. Financial Performance
  • Table 80: Georgetown University Medical Center Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Lewy Body Dementia Market, Sub-Segmentation Of Clinical Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Lewy Body Dementia Market, Sub-Segmentation Of Biomarker-Based Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Lewy Body Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Lewy Body Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Lewy Body Dementia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Lewy Body Dementia Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Lewy Body Dementia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Eli Lilly and Company Financial Performance
  • Figure 77: Mayo Foundation for Medical Education and Research Financial Performance
  • Figure 78: Eisai Co. Ltd. Financial Performance
  • Figure 79: Sumitomo Dainippon Pharma Co. Ltd. Financial Performance
  • Figure 80: Georgetown University Medical Center Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Read More

Global Central Lab Market 2022 – Market Opportunities And Strategies

Read More

What Is The Biohacking Market Overview In 2022?

Read More

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Read More

Lewy Body Dementia Treatment Global Market Report 2025 – By Drug Type (Antidepressants, Antipsychotic Drugs, Benzodiazepine, Carbidopa-Levodopa, Cholinesterase inhibitors, Modafinil), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By Application (Alzheimer’s disease, Dementia, Parkinson’s disease) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Behavioral and Mental Health Software Global Market Report 2025 – By Component (Support Services, Software), By Type (Clinical Software, Financial Software, Administrative Software, Other Types), By Delivery Model (Subscription Model, Ownership Model), By End-Users (Community Clinics, Hospitals, Private Practices) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Behavioral Biometrics Global Market Report 2025 – By Components (Software, Services), By Type (Keystroke Dynamics, Gait Analysis, Signature Analysis, Voice Recognition), By Deployment Model (Cloud, On-Premises), By Application (Identity Proofing, Continuous Authentication, Risk and Compliance Management, Fraud Detection and Prevention), By Verticals (Banking, Financial Services and Insurance (BFSI), Retail, e-Commerce, Healthcare, Government and Defense, Telecommunications, Other verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Behavioral Rehabilitation Global Market Report 2025 – By Treatment Method (Counseling, Medication, Support Services, Other Treatment Methods), By Application (Anxiety Disorders, Mood Disorders, Substance Abuse Disorders, Personality Disorders, Attention Deficit Disorders), By Healthcare Settings (Outpatient Behavioral Rehabilitation, Inpatient Behavioral Rehabilitation, Residential Behavioral Rehabilitation) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cognitive Assessment And Training Global Market Report 2025 – By Component (Solutions, Services), By Organization Size (Small And Medium-sized Enterprises (SMEs), Large Enterprises), By Vertical (Healthcare And Life Sciences, Education, Corporate, Other Verticals), By Application (Clinical Trials, Learning, Research, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cognitive Services Global Market Report 2025 – By Service Type (Data Transformation, Cloud and Web-Based Application Programming Interface, Knowledge Management, Cognitive Risk Intelligence, Data Integration and Cognitive Automation, Training and Support, Communication Monitoring, Consulting and Advisory, Other Service Types), By Deployment (On-Premises, Cloud), By Technology Type (Natural Language Processing, Machine Learning and Deep Learning), By Application (Predictive Maintenance, Marketing Analysis, Quality Management Investigation And Recommendation, Supply Chain Management, Diagnosis And Treatment System, Safety And Security Management, Other Applications), By End User (Healthcare, Banking, Financial Services, and Insurance, IT and Telecommunication, Retail, Manufacturing, Education, Government, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cognitive Analytics Global Market Report 2025 – By Component (Tools, Services ), By Technology Type ( Natural Language Processing (NLP), Machine Learning, Automated Reasoning, Technology Snapshot), By Deployment (On-Premise, Cloud), By Application (Asset Maintenance, Fraud and Risk Management, Customer Analysis and Personalization, Sales and Marketing Management, Supply Chain Management, Other Application), By End Users (Banking, Financial Services, and Insurance (BFSI), Telecommunications and IT, Retail and Consumer Goods, Healthcare and Life Sciences, Manufacturing, Government and Defense, Energy and Utilities, Media and Entertainment, Transportation and Logistics, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Cognitive Computing Global Market Report 2025 – By Technology( Natural Language Processing, Machine Learning, Automated Reasoning, Other Technology), By Deployment Mode( On-premises, Cloud-based), By End Use( Hospitals, Pharmaceuticals, Medical Devices, Insurance, Other End uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Lewy Body Dementia market?

Lewy body dementia (LBD) is a neurodegenerative condition caused by abnormal protein deposits in the brain, impacting cognition, movement, and behavior. This results in a gradual decline in both mental and physical abilities, with symptoms including memory loss, hallucinations, tremors, and motor difficulties. Effective management is essential to address the cognitive and physical challenges associated with the disorder. For further insights on the Lewy Body Dementia market, request a sample here

How will the Lewy Body Dementia market drivers and restraints affect the market dynamics? What forces will shape the Lewy Body Dementia industry going forward?

The Lewy Body Dementia market major growth driver - Rising Prevalence Of Brain-Related Disorders Driving The Market Growth. For further insights on the Lewy Body Dementia market, request a sample here

What is the forecast market size or the forecast market value of the Lewy Body Dementia market?

The Lewy Body Dementia market size has grown strongly in recent years. The lewy body dementia market size has grown strongly in recent years. It will grow from $1.12 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population growth, increasing awareness of neurodegenerative diseases, rise in healthcare expenditures, improved diagnostic criteria, and regulatory approvals for dementia drugs. The lewy body dementia market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing prevalence of dementia, growing investment in research and development, rising demand for early diagnosis, expanding telemedicine adoption, and focus on personalized medicine. Major trends in the forecast period include development of targeted therapies, expansion of clinical trials, advances in diagnostic techniques, technological advancements, and emphasis on novel therapeutics. For further insights on the Lewy Body Dementia market, request a sample here

How is the Lewy Body Dementia market segmented?

The lewy body dementia market covered in this report is segmented –
1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications
3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers For further insights on the Lewy Body Dementia market, request a sample here

Which region has the largest share of the Lewy Body Dementia market? What are the other regions covered in the report?

North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Lewy Body Dementia market, request a sample here.

Who are the major players in the Lewy Body Dementia market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc. . For further insights on the Lewy Body Dementia market, request a sample here.

What are the key trends in the Lewy Body Dementia market?

Major trends in the Lewy Body Dementia market include Research Investments Driving Advancements In Lewy Body Dementia Treatment. For further insights on the Lewy Body Dementia market, request a sample here.

What are the major opportunities in the Lewy Body Dementia market? What are the strategies for the Lewy Body Dementia market?

For detailed insights on the major opportunities and strategies in the Lewy Body Dementia market, request a sample here.

How does the Lewy Body Dementia market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Lewy Body Dementia market growth and SWOT analysis of the Lewy Body Dementia industry, request a sample here.

For detailed insights on Lewy Body Dementia's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Lewy Body Dementia industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Lewy Body Dementia industry,

What are the key dynamics influencing the Lewy Body Dementia market growth? SWOT analysis of the Lewy Body Dementia market. request a sample here.